Home > Business Segment > Formulation > Branded Priscription DrugsBranded Priscription Drugs
Since our inception in 1995, the Medicus division has been catering to the needs of the common man. With a field force of professionally trained sales executives, we have reached to innumerable number of doctors, retailers and stockists along with numerous hospitals, nursing homes and institutions through out India. The Medicus team makes sure that the common man gets superior quality drugs at an affordable price.
Helping our doctors to fight the deadly infections with quality products.
Healing not only the illness but also the spirit of the common man.
Happiness on the faces of the millions with the superior performance of our products has been the underlying motto of our organization.
Medicus has been catering to the changing needs of the medical fraternity with the aim of enabling people whose lives have been disrupted by an illness to return comfortably to their regular activities.
The Medicus portfolio caters to the following categories with a wide variety of choices to offer from:
4. Ortho and Pain
5. Calcium Metabolism
6. Respiratory and Anti-allergic
7. Nutraceuticals & Vitamins
Team Medicus continuously strives to bring in new products into the Indian Pharmaceutical Market which are technologically superior but within the reach of the common man.
Future Plans: Leverage strong selling and distribution capabilities to grow aggressively in the large Indian Pharmaceutical Market supported by introduction of new products in current and new therapeutic segments.
Some of the launches in the recent past include:
2. DUCAL TAB.
3. FUTIZA KIT
Launched in the year 2010, this new division has been incepted with a vision to enlighten the life of people with affordable and quality medicines thus bringing the smile on their faces. This division focuses on diabetes and related complications and cardiology therapy group with currently 14 brands in offering, with sustained release forms also. With all the products being manufactured at our plants, we are in the process to consolidate our name in the highly potential chronic segment with more brands being launched within next 5 years.
The Cardia portfolio caters to the following categories with a wide variety of choices to offer from:
1. Angiotensin Receptor Blocker (ARB)
2. ARB + Diuretic
3. Angiotensin Converting Enzyme Inhibitor (ACE- Inhibitor)
4. ACE- Inhibitor + Diuretics
7. Biguanides + Sulphonylureas
8. Biguanides + Sulphonylureas + Thiazolidinedione